Skip to main content
. Author manuscript; available in PMC: 2013 Feb 22.
Published in final edited form as: J Pharmacol Sci. 2013 Jan 22;121(2):95–102. doi: 10.1254/jphs.12169fp

Fig. 3.

Fig. 3

Plasma TBARS levels (A) and aortic superoxide production (B). NS + HF diet–fed DSS rats showed higher plasma TBARS levels and aortic superoxide production (lucigenin chemiluminescence) than NS diet–fed DSS rats. In NS + HF diet–fed DSS rats, treatment with olmesartan, but not hydralazine, prevented the increases in plasma TBARS levels and aortic superoxide production. TBARS, thiobarbituric acid reactive substances. *P < 0.05: NS/DSS rats vs. NS + HF/DSS rats, NS + HF/DSS rats + olmesartan or NS + HF/DSS rats + hydralazine; †P < 0.05: NS + HF/DSS rats vs. NS + HF/DSS rats + olmesartan or NS + HF/DSS rats + hydralazine.